The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Journal of psychopharmacology (Oxford, England) Oct, 2011 | Pubmed ID: 20305042